Addiction Medicine
From the Journals
Substance abuse boosts COVID hospitalization, death risk, even after vaccination
Investigators found about twice as many individuals with an SUD had a breakthrough COVID-19 infection as their counterparts without an SUD.
From the Journals
Telehealth a game changer for addiction treatment?
“We still need more research to confirm the benefits of telehealth and to determine under what conditions telehealth is best used.”
Feature
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.
From the Journals
COVID-19 hospitalization 80% more likely for smokers
These results contrast with previous studies that have suggested a protective effect of smoking against COVID-19.
Feature
‘Alarming’ increase in fake pills laced with fentanyl, methamphetamine, DEA warns
More than 9.5 million fake pills have been seized so far this year – more than the last 2 years combined.
Commentary
Dopamine and reward: The story of social media
There is a need to establish boundaries between what is beneficial and what is potentially detrimental to our mental health, says Leanna M.W. Lui...
Feature
As opioid deaths climb, human trials begin for vaccine
The first vaccine to enter a trial targets oxycodone.
From the Journals
Opioid overdoses tied to lasting cognitive impairment
One study in the review found that about 39% of people seeking buprenorphine treatment suffered from neurocognitive impairment.
Conference Coverage
Growing proportion of cardiac arrests in U.S. considered opioid related
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.
Feature
The trauma and healing of 9/11 echo in COVID-19
“To me, 9/11 placed psychological first aid on the map,” said Dr. Priscilla Dass-Brailsford, who was involved in early interventions for Sept. 11...
Feature
Toward ‘superhuman cognition’: The future of brain-computer interfaces
Among the big players in this area of research is billionaire entrepreneur Elon Musk, who in 2016 founded Neuralink.